An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
Glucose dehydrogenase (GDH, EC 1.1.1.47) is a versatile oxidoreductase that catalyses the oxidation of glucose to gluconolactone using a variety of electron acceptors, including NAD(P)+ and artificial mediators such as quinones and ferrocene derivatives. This enzyme is a critical component in glucose biosensors (particularly blood glucose monitoring systems), enzymatic biofuel cells, and industrial biotransformations for the production of fine chemicals. The precise and reliable measurement of GDH activity, along with the characterisation of its cofactor specificity, substrate affinity, thermal stability, and electron transfer properties, is fundamental to ensuring sensor accuracy, biocatalytic efficiency, and product consistency. Our specialised detection platform provides a fully validated suite of biochemical and electrochemical assays tailored to GDH from various microbial and recombinant sources, delivering the high-accuracy, actionable data that clients require for quality control, process development, and regulatory submissions.

Clients seeking GDH detection services are typically motivated by one or more of the following strategic objectives: (i) quantifying enzyme activity to verify that each batch meets the specified potency for biosensor strip manufacturing, ensuring rapid and accurate glucose response; (ii) characterising the cofactor specificity (NAD+, NADP+, or pyrroloquinoline quinone PQQ) and determining the kinetic parameters (Km, Vmax, kcat) to support enzyme engineering and optimisation; (iii) monitoring enzyme purity and detecting the presence of contaminating activities (e.g., glucose oxidase, catalase) that could interfere with sensor performance or biocatalytic reactions; (iv) assessing the stability of GDH under various pH, temperature, and storage conditions to determine optimal formulation and shelf-life; (v) evaluating the electron transfer efficiency with different mediators for biofuel cell applications; and (vi) generating comprehensive data packages to support regulatory filings for in vitro diagnostic devices or biocatalyst products. Our service is specifically designed to address these needs with scientific rigour, providing clients with a complete functional and molecular fingerprint of their GDH product.
Our analytical platform comprises four interconnected modules that collectively deliver a comprehensive evaluation of GDH quality and performance. The Activity Quantification Module employs a range of well-established, ISO-compliant methods tailored to the specific cofactor. For NAD(P)+-dependent GDH, we monitor the reduction of NAD(P)+ spectrophotometrically at 340 nm; for PQQ-dependent GDH, we use a coupled electron mediator system (e.g., phenazine methosulfate and dichlorophenolindophenol) with colorimetric detection. We determine the specific activity (U/mg protein) with precision within ±2% RSD and a limit of detection (LOD) as low as 0.005 U/mL. For detailed kinetic characterisation, we calculate Michaelis-Menten parameters with 95% confidence intervals typically within ±5%, and we assess cofactor preference by measuring activity with alternative coenzymes. The Purity and Structural Module uses SDS-PAGE with silver or Coomassie staining, size-exclusion chromatography (SEC-HPLC), and capillary electrophoresis (CE) to assess purity and detect aggregates or fragmentation. We also perform intact mass analysis by ESI-TOF MS to confirm molecular weight and LC-MS/MS for peptide mapping and identification of post-translational modifications. The Stability and Formulation Module subjects the enzyme to accelerated aging conditions (temperatures from 4°C to 60°C, pH 4–9, and various ionic strengths) and monitors residual activity over time. Using Arrhenius modeling, we predict shelf-life and identify degradation pathways. The Electrochemical Module evaluates the performance of GDH in the presence of relevant electron mediators (e.g., ferrocene, ferricyanide, phenanthroline derivatives) using cyclic voltammetry and chronoamperometry. We determine apparent Michaelis-Menten constants for the mediator, current density, and response time, providing essential data for biosensor and biofuel cell development. All modules are validated with certified reference GDH standards and include rigorous quality controls (system suitability, blank subtraction, and replicate analyses).
Our platform consistently delivers performance that surpasses typical industry standards. In activity assays, we achieve signal-to-noise ratios > 200:1 at the LOD, and our kinetic fitting software uses global non-linear regression to provide precise estimates of Km and Vmax, with residual errors < 3%. For purity analysis, our SEC-HPLC method resolves monomer, dimer, and aggregates with retention time reproducibility < 0.2% RSD and peak area precision < 1%. In stability studies, we apply accelerated degradation models that account for both first-order and autocatalytic pathways, providing robust predictions of half-life (t1/2) and activation energy (Ea). Additionally, we offer differential scanning calorimetry (DSC) to determine melting temperature (Tm) and enthalpy change (ΔH), which are critical indicators of conformational stability. For clients requiring detailed characterisation of electron transfer kinetics, we perform rotating disk electrode (RDE) and rotating ring-disk electrode (RRDE) experiments to calculate heterogeneous electron transfer rate constants and catalytic efficiencies. This multi-layered approach ensures that our clients receive not only a simple activity value but a comprehensive understanding of the enzyme's molecular integrity, stability, and functional performance in relevant applications.
Our service offers several unique benefits that directly address client challenges. First, we have developed matrix-specific sample preparation protocols for a wide variety of GDH products—including liquid concentrates, lyophilised powders, fermentation broths, and formulated sensor inks—that effectively remove interfering substances while preserving enzymatic activity, achieving recoveries > 95% for all tested matrices. Second, we maintain a comprehensive reference library of GDH variants from different microbial sources (e.g., Bacillus, Aspergillus, Pseudomonas, recombinant E. coli), enabling rapid benchmarking and identification of product variants. Third, we offer a rapid screening service using a microplate-based spectrophotometric assay that provides semi-quantitative activity data within 2 hours of sample receipt—ideal for in-process control and early-stage formulation development. Fourth, our customised stability and formulation studies can simulate real-world processing conditions (including exposure to organic solvents, humidity, and temperature fluctuations) and provide statistically robust recommendations for stabilisers, buffers, and storage conditions to maximise shelf-life. Fifth, we provide integrated data interpretation that links activity, purity, and stability to industrial performance metrics (e.g., biosensor response time, shelf-life of test strips, biofuel cell power output), enabling clients to predict full-scale performance without extensive pilot trials. Sixth, all our methods comply with ICH Q2(R1), AOAC, and ISO 17025 guidelines, and we supply full validation dossiers (specificity, linearity, accuracy, precision, LOD, LOQ, robustness) along with detailed SOPs, ensuring that our data are readily accepted by regulatory authorities and customers. Our team of enzymologists, electrochemists, and protein chemists provides consultative interpretation, helping clients to translate analytical findings into actionable improvements—for example, recommending optimal pH for mediator compatibility, identifying heat-labile fractions, or formulating effective stabilisation strategies.
Our reporting transforms analytical data into strategic operational knowledge. We deliver a comprehensive final report that includes: (i) an executive dashboard with key metrics (specific activity, Km for glucose and cofactor, purity %, shelf-life estimate, mediator efficiency, and contaminant levels) presented as concise scorecards; (ii) a detailed analytical section containing raw data, calibration curves, chromatograms, electrochemical traces, and kinetic fits; (iii) a statistical comparison of samples against reference standards or historical batches, with p-values and confidence intervals; and (iv) an interpretive narrative that contextualises the results—for example, explaining how a shift in pH optimum may affect sensor performance, or how a low level of glucose oxidase contamination could lead to inaccurate readouts. For clients with multiple batches or formulation variants, we provide multivariate analysis (PCA, PLS-DA) to identify critical quality attributes and to guide process optimisation. We also offer predictive models that estimate biosensor performance or biofuel cell efficiency based on initial enzyme characteristics and formulation parameters, enabling proactive control of production runs. All raw data files (e.g., .xlsx, .raw, .cdf) are supplied to ensure full transparency and re-analysis capability.
The versatility of our GDH detection service spans a wide range of sectors. In biosensor manufacturing, our assays support the quality control of enzyme electrodes for glucose monitoring in clinical and home-use devices. In biofuel cell development, our electrochemical characterisation provides essential data for optimising anode performance and power density. In industrial biocatalysis, we characterise GDH preparations used in the production of chiral intermediates and fine chemicals. In enzyme manufacturing and formulation, our stability and purity profiling ensure product reliability and regulatory compliance. In academic and industrial R&D, our detailed kinetic and structural data support enzyme engineering, directed evolution, and process modelling. In regulatory submissions, our validated data packages facilitate the approval of in vitro diagnostic devices containing GDH. Our ability to tailor the analytical package to the specific enzyme source, application, and regulatory framework ensures that we serve both small research groups and large multinational enterprises with equal rigor and responsiveness.
We are dedicated to advancing glucose dehydrogenase analytics through continuous technological improvement. Our current R&D includes the development of lab-on-a-chip microfluidic systems for real-time, label-free activity and mediator screening, and the application of machine learning algorithms to predict enzyme performance from primary sequence and structural features. We actively participate in inter-laboratory proficiency testing for enzyme activity and protein analysis, and we contribute to the development of standard reference materials for industrial enzymes. Our quality management system is ISO 9001 and ISO 17025 certified, and we follow GLP for all regulatory studies. We offer flexible engagement models—from single-sample analysis to multi-year collaborative projects—with dedicated project managers, volume discounts, and priority handling for time-sensitive samples. Our global logistics provide specialised shipping kits (with stabilising buffers and temperature control) to preserve enzyme activity during transit. Turnaround times range from 2 business days for rapid activity screening to 12 business days for comprehensive kinetic, electrochemical, and stability profiling. We maintain open communication, providing preliminary results upon request and final reports with expert commentary. Our success is measured by the confidence our clients have in their products and processes. We invite you to partner with us to unlock the full potential of your glucose dehydrogenase-based technologies.
In summary, our glucose dehydrogenase detection service delivers a comprehensive, precise, and application-oriented analytical solution that integrates enzyme activity, purity, stability, and electrochemical characterisation. By combining advanced instrumentation with deep biochemical and electrochemical expertise, we empower our clients to ensure product quality, optimise biosensor performance, and accelerate innovation. We look forward to supporting your glucose dehydrogenase analysis needs with our state-of-the-art analytical platform.